Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cefixime vs Benzathine Penicillin G for Early Syphilis
NCT06907316Phase 4Terminated
- Sponsor
- Bulovka University Hospital
- Start
- Jul 2021
- Primary completion
- Aug 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of cefixime in syphilis (2 arms), sponsored by Bulovka University Hospital. Primary endpoint: Serological cure at 3 months. Started Jul 2021; status: terminated.
02
Drugs
cefixime
03
Conditions
syphilis
Beyond the preview
Go deeper on NCT06907316.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06907316.